IRIS
FILICE, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.431
EU - Europa 2.235
AS - Asia 1.948
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
AF - Africa 3
Totale 7.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.420
CN - Cina 1.762
IE - Irlanda 759
UA - Ucraina 463
FI - Finlandia 265
DE - Germania 262
SE - Svezia 192
SG - Singapore 146
IT - Italia 109
GB - Regno Unito 93
FR - Francia 43
BE - Belgio 20
JP - Giappone 13
CA - Canada 11
IN - India 8
NL - Olanda 7
AU - Australia 6
IR - Iran 6
PL - Polonia 6
RU - Federazione Russa 6
EU - Europa 4
HK - Hong Kong 3
AT - Austria 2
CO - Colombia 2
IQ - Iraq 2
MD - Moldavia 2
MU - Mauritius 2
NP - Nepal 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IS - Islanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.632
Salva come PNG Salva come JPEG
Città #
Dublin 759
Chandler 740
Jacksonville 560
Nanjing 496
Boardman 237
Nanchang 215
Ashburn 189
Beijing 181
Princeton 178
Lawrence 155
Houston 152
Shenyang 144
Changsha 142
Hebei 134
Medford 133
Wilmington 125
Jiaxing 106
Singapore 102
Tianjin 89
Ann Arbor 87
Hangzhou 72
Helsinki 69
Shanghai 56
New York 49
Milan 29
Norwalk 29
Woodbridge 25
Verona 23
Brussels 19
Fairfield 16
Pavia 15
Des Moines 13
Tokyo 12
Kunming 11
Seattle 11
Ningbo 10
Zhengzhou 10
Jinan 9
Los Angeles 9
Falkenstein 8
Falls Church 8
Orange 8
Toronto 8
Washington 8
Dallas 7
Pune 7
Redwood City 7
Chicago 6
Guangzhou 6
Lanzhou 6
San Francisco 6
Taizhou 6
Berlin 5
Frankfurt am Main 5
Sacramento 5
Tappahannock 5
Auburn Hills 4
Haikou 4
Poznan 4
Zanjan 4
Andover 3
Borås 3
Fuzhou 3
Sassari 3
Changchun 2
Chisinau 2
Envigado 2
Fayetteville 2
Jawalakhel 2
Las Vegas 2
Munich 2
Piscataway 2
Rockville 2
Scuola 2
Senigallia 2
Shijiazhuang 2
Aarau 1
Amsterdam 1
Asyut 1
Baku 1
Bloomfield 1
Bolzano 1
Brescia 1
Brunico 1
Buffalo 1
Cagliari 1
Canberra 1
Chaozhou 1
Chapel Hill 1
Cuggiono 1
Dearborn 1
Eindhoven 1
Groningen 1
Hamilton 1
Harbin 1
Hong Kong 1
Karby 1
Kashan 1
Kemerovo 1
Latham 1
Totale 5.598
Salva come PNG Salva come JPEG
Nome #
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1 117
Predictors of bacterial pneumonia in Evaluation of SUbcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). 112
The Pavia consensus statement 90
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 83
Mice and rabbits: Animal models for HIV-1 infection 83
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera 82
Host factors affecting the outcome of treatment of hepatitis C 81
Aggressive daily interferon therapy in HIV-HCV coinfected patients 78
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 77
In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics 76
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. 76
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure 75
IgM-IFA, IgM-ELISA, DS-IgM-ELISA, IgM-ISAGA, performed on whole serum and IgM fractions, for detection of IgM anti-toxoplasma antibodies during pregnancy 72
Management of hepatitis C in human immunodeficiency virus-infected patients 71
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 69
Accuracy of ultrasound imaging technique for assessing lipoatrophy in HIV-infected subjects. 69
Chemotherapy of toxoplasmic encephalitis in AIDS patients 69
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 68
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 67
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study 67
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. 67
Hepatotoxicity and nelfinavir: a meta-analysis 66
Malattie Infettive 66
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 66
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 66
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1 65
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 65
Comparison between IgM-IFA and DS-IgM-ELISA performed on IgM fractions and whole sera in acute acquired toxoplasmosis 64
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 64
Transfusion-transmitted virus infection in HIV-1-seropositive patients 64
A New complement fixation test for toxoplasmosis. Comparison with other serological methods 63
Minimal invasive Treatment for Hydatid Abdominal Cysts: PAIR (Puncture, Aspiration, Injection, Reaspiration)- State of the Art 63
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 63
Point shear wave elastography method for assessing liver stiffness. 63
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 63
Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis 62
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 61
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study 60
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 60
Entamoebiasi e parassitosi intestinali in un centro di ricovero psichiatrico.Valutazione di efficacia di protocolli di trattamento chemioprofilattico-chemioterapeutico 60
Malattie Infettive 59
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 59
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 59
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 58
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 58
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 57
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 56
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 56
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 56
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor 56
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 55
Evolution of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy from 2000 to 2010. 55
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. 55
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 55
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 55
Pathogenesis of liver damage in HCV-HIV patients. 54
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 54
Pathogenesis of liver damage in HCV-HIV patients 54
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 54
Detection of IgM anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis 53
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 53
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 53
Epatiti Virali Acute 53
Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review 52
Manuale di Virologia Clinica 52
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 52
Epatocarcinoma nei soggetti HIV positivi 51
Natural history of chronic hepatitis B in co-infected patients. 51
Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles 51
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 51
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study 51
Human immunodeficiency virus (HIV): an ultrastructural study 51
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 50
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. 50
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort 49
Tuberculosis meningitis in adults: 5 cases 49
Daily interferon regimen for chronic hepatitis c. A prospective randomized study. 49
Rate of CD4+ cell count increase over periods of viral load suppressione: relationship with the number of previous virological failures. 49
Recent advances in AIDS researches 49
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers 49
General issues on microbial translocation in HIV-infected patients 49
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 49
[New trends in the therapy of cryptococcosis in AIDS patients] 49
Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs? 48
Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection. 48
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients. 48
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C 48
Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo 48
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 48
HCV chronic hepatitis in patients with HIV: clinical management issues 48
Duration of first-line antiretroviral therapy with enofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 47
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients 46
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 46
Prevalence of HIV-1 inetgrase mutations related to resistance to dolutegravir in raltegravir naive and pretrated patients. 45
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers 45
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 44
Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. 44
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 43
Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies 43
[Protocols for the diagnostic verification of lymph node toxoplasmosis] 43
Totale 5.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020402 0 0 0 0 0 0 7 100 8 154 126 7
2020/2021882 102 81 31 89 3 121 10 128 32 128 123 34
2021/2022660 13 5 6 3 12 10 17 42 31 5 112 404
2022/20232.120 244 152 16 173 220 217 0 116 893 9 44 36
2023/2024641 63 126 29 38 72 166 12 54 8 17 17 39
2024/2025400 38 180 35 60 18 69 0 0 0 0 0 0
Totale 7.788